Lake Washington Vascular VenaSeal™ Post-Market Evaluation
NCT ID: NCT04146168
Last Updated: 2019-10-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
124 participants
OBSERVATIONAL
2019-11-30
2020-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VenaSeal
Complete closure of previously treated veins will be assessed via ultrasound
Ultrasound
Closure of previously treated veins (with Venaseal) will be assessed via ultrasound.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound
Closure of previously treated veins (with Venaseal) will be assessed via ultrasound.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\-
Exclusion Criteria
\-
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Vascular
INDUSTRY
Lake Washington Vascular
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kathleen Gibson, MD
Role: PRINCIPAL_INVESTIGATOR
Lake Washington Vascular, PLLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lake Washington Vascular
Bellevue, Washington, United States
Lake Washington Vascular
Issaquah, Washington, United States
Lake Washington Vascular
Kirkland, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Kim Glorieux, BS, BS, CCRC
Role: primary
Kim Glorieux, BS, BS, CCRC
Role: primary
Kim Glorieux, BS, BS, CCRC
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-02
Identifier Type: -
Identifier Source: org_study_id